Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-28 @ 9:56 AM
Study NCT ID:
NCT03288350
Status:
UNKNOWN
Last Update Posted:
2018-03-22
First Post:
2017-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)
Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-09-15
First Submit QC Date:
None
Study First Post Date:
2017-09-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-20
Last Update Post Date:
2018-03-22
Last Update Post Date Type:
ACTUAL